Drug Profile
MAK 2124
Alternative Names: MAK-2124Latest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator MakScientific
- Class Analgesics; Anti-inflammatories; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory pain
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for preclinical development in Inflammatory-pain in USA (PO)
- 27 Oct 2017 Preclinical trials in Inflammatory pain in USA (PO) before October 2017 (MAKScientific pipeline, October 2017)